Research Output per year
Fingerprint Dive into the research topics where Tapan Mahendra Kadia is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 37 Similar Profiles
Acute Myeloid Leukemia
Medicine & Life Sciences
Myelodysplastic Syndromes
Medicine & Life Sciences
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Medicine & Life Sciences
decitabine
Medicine & Life Sciences
Survival
Medicine & Life Sciences
Therapeutics
Medicine & Life Sciences
Cytarabine
Medicine & Life Sciences
Azacitidine
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1999 2019
1
Citation
(Scopus)
Acute promyelocytic leukemia in a patient with chronic lymphocytic leukemia—A case report
Boddu, P., Schlette, E., Thakral, B., Tang, G., Pemmaraju, N., Kadia, T., Ferrajoli, A., Ravandi, F., Wierda, W. & Jain, N., Sep 2019, In : Hematology/ Oncology and Stem Cell Therapy. 12, 3, p. 161-165 5 p.Research output: Contribution to journal › Article
Acute Promyelocytic Leukemia
B-Cell Chronic Lymphocytic Leukemia
Tretinoin
Leukemia
Bone Marrow Examination
3
Citations
(Scopus)
Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs
Jain, P., Kantarjian, H., Boddu, P. C., Nogueras-González, G. M., Verstovsek, S., Garcia-Manero, G., Borthakur, G., Sasaki, K., Kadia, T. M., Sam, P., Ahaneku, H., O’Brien, S., Estrov, Z., Ravandi, F., Jabbour, E. & Cortes, J. E., Mar 26 2019, In : Blood Advances. 3, 6, p. 851-861 11 p.Research output: Contribution to journal › Article
Open Access
Leukemia, Myeloid, Chronic Phase
Protein-Tyrosine Kinases
Incidence
Confidence Intervals
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
A phase 2 clinical trial of eltrombopag for treatment of patients with myelodysplastic syndromes after hypomethylating-agent failure
Swaminathan, M., Borthakur, G., Kadia, T. M., Ferrajoli, A., Alvarado, Y., Pemmaraju, N., Bodden, K., Yearby, B., Konopleva, M., Khoury, J., Bueso-Ramos, C., Garcia-Manero, G. & DiNardo, C. D., Jul 29 2019, In : Leukemia and Lymphoma. 60, 9, p. 2207-2213 7 p.Research output: Contribution to journal › Article
Myelodysplastic Syndromes
Clinical Trials
Blood Platelets
Therapeutics
Standard of Care
Clonal Dynamics and Clinical Implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML)
Tanaka, T., Morita, K., Wang, F., Little, L., Gumbs, C., Matthews, J., DiNardo, C. D., Kadia, T. M., Ravandi, F., Konopleva, M. Y., Kantarjian, H. M., Champlin, R. E., Garcia-Manero, G., Futreal, P. A. & Takahashi, K., Nov 13 2019, In : Blood. 134, 1, 1 p.Research output: Contribution to journal › Article
Hematopoiesis
Acute Myeloid Leukemia
Research
Advisory Committees
Actinium
1
Citation
(Scopus)
Clonal hematopoiesis of indeterminate potential–associated mutations and risk of comorbidities in patients with myelodysplastic syndrome
Naqvi, K., Sasaki, K., Montalban Bravo, G., Alfonso Pierola, A., Yilmaz, M., Short, N. J., Assi, R., Jabbour, E. J., Ravandi-Kashani, F., Kadia, T. M., Pierce, S., Takahashi, K., Nogueras Gonzalez, G., Kanagal Shamanna, R., Patel, K. P., Soltysiak, K. A., Kantarjian, H. M. & Garcia-Manero, G., Jul 1 2019, In : Cancer. 125, 13, p. 2233-2241 9 p.Research output: Contribution to journal › Article
Myelodysplastic Syndromes
Hematopoiesis
Comorbidity
Mutation
Janus Kinase 2